440 filings
Page 5 of 22
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
4 Apr 17
Current report (foreign)
12:00am
20-F/A
2016 FY
XTLB
X.T.L. Biopharmaceuticals Ltd.
3 Apr 17
Annual report (foreign) (amended)
12:00am
20-F
2016 FY
XTLB
X.T.L. Biopharmaceuticals Ltd.
Annual report (foreign)
30 Mar 17
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
30 Mar 17
Current report (foreign)
12:00am
D
XTLB
X.T.L. Biopharmaceuticals Ltd.
29 Mar 17
$2.8M in equity / options / securities to be acquired, sold $2.8M, 22 investors
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
22 Mar 17
Current report (foreign)
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
9 Mar 17
Current report (foreign)
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
7 Mar 17
Current report (foreign)
12:00am
D
XTLB
X.T.L. Biopharmaceuticals Ltd.
1 Mar 17
$2.5M in options / securities to be acquired, sold $2.5M, 5 investors
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
1 Mar 17
Current report (foreign)
12:00am
SC 13G
Intracoastal Capital, LLC
27 Feb 17
XTL Biopharmaceuticals LTD
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
22 Feb 17
Current report (foreign)
12:00am
424B5
XTLB
X.T.L. Biopharmaceuticals Ltd.
22 Feb 17
Prospectus supplement for primary offering
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
17 Feb 17
XTL Biopharmaceuticals Announces $2.5 Million Registered Direct Offering
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
25 Jan 17
Current report (foreign)
12:00am
SC 13G/A
Sabby Management, LLC
6 Jan 17
XTL Biopharmaceuticals LTD
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
5 Jan 17
Current report (foreign)
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
5 Jan 17
Current report (foreign)
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
6 Dec 16
Current report (foreign)
12:00am
6-K
XTLB
X.T.L. Biopharmaceuticals Ltd.
14 Nov 16
Current report (foreign)
12:00am